Article Text

Download PDFPDF
Disruptive innovation in rheumatology: new networks of global public–private partnerships are needed to take advantage of scientific progress

Statistics from Altmetric.com

Footnotes

  • TWH and VMH are joint first authors.

  • Handling editor Josef S Smolen

  • Twitter @soumya_boston

  • Correction notice This article has been corrected since it published Online First. The second author's name has been corrected and the joint first author statement added.

  • Contributors Written by MVH and TWJH. Intellectual and textual contributions from all others.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient and public involvement Patients and/or the public were involved in the design, or conduct, or reporting, or dissemination plans of this research. Refer to the Methods section for further details.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.